chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness, Pain, Productive cough, Vomiting
Clinical narrative: diarrhea; feel a little shaky and a little off; feel like post flu; very bad body aches; lots of sputum; nausea; vomiting; terrible headache; chills; really hit me hard; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches) and PRODUCTIVE COUGH (lots of sputum) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches), PRODUCTIVE COUGH (lots of sputum), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (terrible headache), CHILLS (chills) and MUSCULOSKELETAL DISCOMFORT (really hit me hard). At the time of the report, DIARRHOEA (diarrhea), NERVOUSNESS (feel a little shaky and a little off), INFLUENZA LIKE ILLNESS (feel like post flu), PAIN (very bad body aches), PRODUCTIVE COUGH (lots of sputum), NAUSEA (nausea), VOMITING (vomiting), HEADACHE (terrible headache), CHILLS (chills) and MUSCULOSKELETAL DISCOMFORT (really hit me hard) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Pain, Pain in extremity, Pruritus
Clinical narrative: red patch on her arm that itch a lot and redness is evident; Allergic reaction; pain all over the body; itchiness; arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (pain all over the body), PRURITUS (itchiness), PAIN IN EXTREMITY (arm soreness), ERYTHEMA (red patch on her arm that itch a lot and redness is evident) and HYPERSENSITIVITY (Allergic reaction) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included Multivitamins                                                  supplement, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), Probiotics                                                     supplement and Tagamet                                                        Antacid for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced PAIN (pain all over the body), PRURITUS (itchiness) and PAIN IN EXTREMITY (arm soreness). On 02-Feb-2021, the patient experienced ERYTHEMA (red patch on her arm that itch a lot and redness is evident) and HYPERSENSITIVITY (Allergic reaction). On 25-Jan-2021, PAIN (pain all over the body) had resolved. At the time of the report, PRURITUS (itchiness), PAIN IN EXTREMITY (arm soreness), ERYTHEMA (red patch on her arm that itch a lot and redness is evident) and HYPERSENSITIVITY (Allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Applied Hyderocortisone cream 1%.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Nasal congestion
Clinical narrative: congestion; headache; chills; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of NASAL CONGESTION (congestion), HEADACHE (headache) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced NASAL CONGESTION (congestion), HEADACHE (headache) and CHILLS (chills). At the time of the report, NASAL CONGESTION (congestion), HEADACHE (headache) and CHILLS (chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral
Clinical narrative: her tongue got tingly for several hours; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA ORAL (her tongue got tingly for several hours) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA ORAL (her tongue got tingly for several hours). On 23-Jan-2021, PARAESTHESIA ORAL (her tongue got tingly for several hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were also not reported  Treatment for the event was not reported.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: shoulder pain both side, but most prominent in the left side; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (shoulder pain both side, but most prominent in the left side) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN, CAFFEINE, CALCIUM CITRATE, CALCIUM GLUCONATE, VITAMINS NOS (BIOPLUS) and Hypochloride for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (shoulder pain both side, but most prominent in the left side). At the time of the report, ARTHRALGIA (shoulder pain both side, but most prominent in the left side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details are not provided by reporter.   Reporter did not allow further contact
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia oral, Vaccination complication
Clinical narrative: weird tingling in her mouth.; Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.; symptoms were on both sides of her face.; This spontaneous case was reported by a physician and describes the occurrence of PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PARAESTHESIA ORAL (weird tingling in her mouth.), HYPOAESTHESIA (Within 25 minutes, the numbness and tingling had spread to her face and behind her ear.) and VACCINATION COMPLICATION (symptoms were on both sides of her face.) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site swelling
Clinical narrative: arm swollen; arm a little red; arm with a bump; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (arm a little red) and VACCINATION SITE INDURATION (arm with a bump) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included CALCIUM and VITAMINS NOS for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (arm a little red) and VACCINATION SITE INDURATION (arm with a bump). At the time of the report, VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (arm a little red) and VACCINATION SITE INDURATION (arm with a bump) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up received and Contact information was updated.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: diagnosed with Shingles; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (diagnosed with Shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced HERPES ZOSTER (diagnosed with Shingles). At the time of the report, HERPES ZOSTER (diagnosed with Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.    Treatment medication included Acyclovir from 20 Jan2021 to 29 Jan 2021.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 27-Jan-2021: No specific follow-up information recorded.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Chills, Myalgia
Clinical narrative: Temperature; Body aches; Chills; This spontaneous case was reported by a nurse and describes the occurrence of BODY TEMPERATURE INCREASED (Temperature), MYALGIA (Body aches) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced BODY TEMPERATURE INCREASED (Temperature), MYALGIA (Body aches) and CHILLS (Chills). At the time of the report, BODY TEMPERATURE INCREASED (Temperature), MYALGIA (Body aches) and CHILLS (Chills) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Inflammation, Myalgia, Peripheral swelling
Clinical narrative: Fever; deep inflammation; redness; Swelling hand; headache; muscle pain; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand) and HEADACHE (headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand), HEADACHE (headache) and MYALGIA (muscle pain). At the time of the report, PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand), HEADACHE (headache) and MYALGIA (muscle pain) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter.  No treatment was reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; deep inflammation; redness; Swelling hand; headache; muscle pain; This spontaneous case was reported by a health care professional and describes the occurrence of PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand) and HEADACHE (headache) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand), HEADACHE (headache) and MYALGIA (muscle pain). At the time of the report, PYREXIA (Fever), INFLAMMATION (deep inflammation), ERYTHEMA (redness), PERIPHERAL SWELLING (Swelling hand), HEADACHE (headache) and MYALGIA (muscle pain) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter.  No treatment was reported.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Headache, Myalgia
Clinical narrative: diarrhea; Headache; muscle pain; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), HEADACHE (Headache), MYALGIA (muscle pain) and FATIGUE (fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (diarrhea), HEADACHE (Headache), MYALGIA (muscle pain) and FATIGUE (fatigue). At the time of the report, DIARRHOEA (diarrhea), HEADACHE (Headache), MYALGIA (muscle pain) and FATIGUE (fatigue) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Felt lousy after the second dose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt lousy after the second dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (Felt lousy after the second dose). At the time of the report, MALAISE (Felt lousy after the second dose) outcome was unknown. Not Provided    No concomitant medications were provided by the reporter Treatment information was not provided by the reporter   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Insomnia, Vaccination site pain
Clinical narrative: Tired; Cold; Had trouble sleeping last night; Had a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Cold), INSOMNIA (Had trouble sleeping last night), FATIGUE (Tired) and VACCINATION SITE PAIN (Had a sore arm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028120A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (Had a sore arm). On 05-Feb-2021, the patient experienced FEELING COLD (Cold) and INSOMNIA (Had trouble sleeping last night). On 06-Feb-2021, the patient experienced FATIGUE (Tired). At the time of the report, FEELING COLD (Cold), INSOMNIA (Had trouble sleeping last night), FATIGUE (Tired) and VACCINATION SITE PAIN (Had a sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported  No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Dizziness postural, Dysuria, Fall
Clinical narrative: Felt dizzy bending over; Lack of appetite.; Fell; Acting draggy; Fever 101 F; Difficulty urinating.; A spontaneous report was received from a consumer, concerning a 68-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events difficulty in urinating/dysuria, fever, felt dizzy bending over/dizziness postural, fall, acting draggy/lethargy and lack of appetite.  The patient's medical history included polycythemia and hypertension. On an unspecified date in Oct 2020, the patient experienced COVID. No relevant concomitant medications were reported.  On 05 Feb 2021, at 12:00 pm, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch number: 011M20A) on left arm for prophylaxis of COVID-19 infection.  On 05 Feb 2021, the night of vaccination, the patient experienced the event difficulty in urinating (dysuria). On 06 Feb 2021 (early morning), the patient developed the events fever with a body temperature of 101 F, felt dizzy upon bending over and fell. The patient was acting draggy and had lack of appetite.  Treatment details included Tylenol for fever.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, difficulty urinating, fever 101 F, felt dizzy bending over and fell was considered as resolved on 6 Feb 2021. On 07 Feb 2021 the outcome of events, acting draggy, lack of appetite was resolved.; Sender's Comments:  MOD21-022987:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia
Clinical narrative: Felt dizzy bending over; Lack of appetite.; Fell; Acting draggy; Fever 101 F; Difficulty urinating.; A spontaneous report was received from a consumer, concerning a 68-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events difficulty in urinating/dysuria, fever, felt dizzy bending over/dizziness postural, fall, acting draggy/lethargy and lack of appetite.  The patient's medical history included polycythemia and hypertension. On an unspecified date in Oct 2020, the patient experienced COVID. No relevant concomitant medications were reported.  On 05 Feb 2021, at 12:00 pm, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch number: 011M20A) on left arm for prophylaxis of COVID-19 infection.  On 05 Feb 2021, the night of vaccination, the patient experienced the event difficulty in urinating (dysuria). On 06 Feb 2021 (early morning), the patient developed the events fever with a body temperature of 101 F, felt dizzy upon bending over and fell. The patient was acting draggy and had lack of appetite.  Treatment details included Tylenol for fever.  Action taken with mRNA-1273 in response to the events was unknown.   The outcome of events, difficulty urinating, fever 101 F, felt dizzy bending over and fell was considered as resolved on 6 Feb 2021. On 07 Feb 2021 the outcome of events, acting draggy, lack of appetite was resolved.; Sender's Comments:  MOD21-022987:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Erythema, Fatigue, Headache, Pain
Clinical narrative: Swollen; Red; Body aches; Dry cough; Headache; Fatigue; Slight fever 99.9; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen), ERYTHEMA (Red), PAIN (Body aches), COUGH (Dry cough) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body aches), COUGH (Dry cough), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Slight fever 99.9). On 04-Feb-2021, the patient experienced SWELLING (Swollen) and ERYTHEMA (Red). On 04-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, SWELLING (Swollen), ERYTHEMA (Red), PAIN (Body aches), COUGH (Dry cough), FATIGUE (Fatigue) and PYREXIA (Slight fever 99.9) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant description included high blood pressure, and cholesterol.  Treatment medication was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling
Clinical narrative: Swollen; Red; Body aches; Dry cough; Headache; Fatigue; Slight fever 99.9; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swollen), ERYTHEMA (Red), PAIN (Body aches), COUGH (Dry cough) and HEADACHE (Headache) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body aches), COUGH (Dry cough), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Slight fever 99.9). On 04-Feb-2021, the patient experienced SWELLING (Swollen) and ERYTHEMA (Red). On 04-Feb-2021, HEADACHE (Headache) had resolved. At the time of the report, SWELLING (Swollen), ERYTHEMA (Red), PAIN (Body aches), COUGH (Dry cough), FATIGUE (Fatigue) and PYREXIA (Slight fever 99.9) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant description included high blood pressure, and cholesterol.  Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Rash; Achiness; Arm Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Achiness), PAIN IN EXTREMITY (Arm Pain) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Feb-2021, the patient experienced PAIN IN EXTREMITY (Achiness) and PAIN IN EXTREMITY (Arm Pain). On 23-Feb-2021, the patient experienced RASH (Rash). On 21-Feb-2021, PAIN IN EXTREMITY (Achiness) and PAIN IN EXTREMITY (Arm Pain) had resolved. At the time of the report, RASH (Rash) was resolving.            Concomitant medications was not provided Treatment for the events included Benadryl for rash.   Reporter did not allow further contact
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Diarrhoea, Fatigue, Flushing, Malaise
Clinical narrative: feeling a flush in my face; was tired most of the day; Severe aching pain in both legs; Call into worksick; Severe diarrhea; Felt cold; Nasty taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), NASOPHARYNGITIS (Felt cold), AGEUSIA (Nasty taste in mouth), PAIN IN EXTREMITY (Severe aching pain in both legs) and FLUSHING (feeling a flush in my face) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes since 2006 and Drug allergy (Sulfer , macrobid). Concomitant products included METFORMIN from 06-Jan-2006 to an unknown date for Diabetes, OMEPRAZOLE from 2006 to an unknown date for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced NASOPHARYNGITIS (Felt cold) and AGEUSIA (Nasty taste in mouth). On 04-Feb-2021, the patient experienced DIARRHOEA (Severe diarrhea), PAIN IN EXTREMITY (Severe aching pain in both legs) and MALAISE (Call into worksick). On an unknown date, the patient experienced FLUSHING (feeling a flush in my face) and FATIGUE (was tired most of the day). On 03-Feb-2021, NASOPHARYNGITIS (Felt cold) and AGEUSIA (Nasty taste in mouth) had resolved. On 04-Feb-2021, DIARRHOEA (Severe diarrhea) and PAIN IN EXTREMITY (Severe aching pain in both legs) had resolved. At the time of the report, FLUSHING (feeling a flush in my face), MALAISE (Call into worksick) and FATIGUE (was tired most of the day) outcome was unknown.      No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up was received on 26 April 2021. Informations on patient demographics ,new events ( flushed face , feeling sick and tired all the time), other relevant history , concomitant medications and second dose information were added.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain in extremity
Clinical narrative: feeling a flush in my face; was tired most of the day; Severe aching pain in both legs; Call into worksick; Severe diarrhea; Felt cold; Nasty taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), NASOPHARYNGITIS (Felt cold), AGEUSIA (Nasty taste in mouth), PAIN IN EXTREMITY (Severe aching pain in both legs) and FLUSHING (feeling a flush in my face) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes since 2006 and Drug allergy (Sulfer , macrobid). Concomitant products included METFORMIN from 06-Jan-2006 to an unknown date for Diabetes, OMEPRAZOLE from 2006 to an unknown date for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced NASOPHARYNGITIS (Felt cold) and AGEUSIA (Nasty taste in mouth). On 04-Feb-2021, the patient experienced DIARRHOEA (Severe diarrhea), PAIN IN EXTREMITY (Severe aching pain in both legs) and MALAISE (Call into worksick). On an unknown date, the patient experienced FLUSHING (feeling a flush in my face) and FATIGUE (was tired most of the day). On 03-Feb-2021, NASOPHARYNGITIS (Felt cold) and AGEUSIA (Nasty taste in mouth) had resolved. On 04-Feb-2021, DIARRHOEA (Severe diarrhea) and PAIN IN EXTREMITY (Severe aching pain in both legs) had resolved. At the time of the report, FLUSHING (feeling a flush in my face), MALAISE (Call into worksick) and FATIGUE (was tired most of the day) outcome was unknown.      No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Follow up was received on 26 April 2021. Informations on patient demographics ,new events ( flushed face , feeling sick and tired all the time), other relevant history , concomitant medications and second dose information were added.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse reaction, Ageusia, Anosmia, Chills, Cough
Clinical narrative: Very bad reaction; terrible chills that lasted 30 minutes,Her teeth were clanking; Flu-like symptoms that lasted for 72 hours; Lost taste; Lost smell; Her cough was back; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste) and ANOSMIA (Lost smell) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste), ANOSMIA (Lost smell), COUGH (Her cough was back) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste), ANOSMIA (Lost smell), COUGH (Her cough was back) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Very bad reaction; terrible chills that lasted 30 minutes,Her teeth were clanking; Flu-like symptoms that lasted for 72 hours; Lost taste; Lost smell; Her cough was back; Fever; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste) and ANOSMIA (Lost smell) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste), ANOSMIA (Lost smell), COUGH (Her cough was back) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, ADVERSE REACTION (Very bad reaction), CHILLS (terrible chills that lasted 30 minutes,Her teeth were clanking), INFLUENZA LIKE ILLNESS (Flu-like symptoms that lasted for 72 hours), AGEUSIA (Lost taste), ANOSMIA (Lost smell), COUGH (Her cough was back) and PYREXIA (Fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mouth swelling, Pruritus, Swollen tongue
Clinical narrative: serious itching in extremities; tongue starting to swell; upper palate starting to swell; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (serious itching in extremities), SWOLLEN TONGUE (tongue starting to swell) and MOUTH SWELLING (upper palate starting to swell) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2021, the patient experienced PRURITUS (serious itching in extremities), SWOLLEN TONGUE (tongue starting to swell) and MOUTH SWELLING (upper palate starting to swell). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency. At the time of the report, PRURITUS (serious itching in extremities), SWOLLEN TONGUE (tongue starting to swell) and MOUTH SWELLING (upper palate starting to swell) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were provided by the reporter She spoke to doctor who advised her to take Benadryl first before resorting to EpiPen that she keeps for anaphylactic reaction to bee stings.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 2 aspirin. At the time of the report, PAIN IN EXTREMITY (Arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 05-Feb-2021: FU makes case valid. NNI. Event start date updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of this event, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain lower, Vaccination site pain
Clinical narrative: serious lower stomach pain; soreness in injection arm.; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.). At the time of the report, ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Feb-2021 and was forwarded to Moderna on 07-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 01-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.). At the time of the report, ABDOMINAL PAIN LOWER (serious lower stomach pain) and VACCINATION SITE PAIN (soreness in injection arm.) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Fatigue
Clinical narrative: No appetite; No energy; Wiped out; A spontaneous report was received from a consumer concerning, a 84-years-old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events no appetite, wiped out and no energy.  The patient's medical history included cholesterol and macular degeneration. Products known to have been used by the patient, within two weeks prior to the event, included simvastatin, multivitamin, vitamin D and vitamins for eye.   On 5 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (batch number: 015M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 6 Feb 2021, the patient experienced the events no appetite, wiped out and no energy. Treatment for the events included paracetamol and acetaminophen  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of events, no appetite, wiped out and no energy was unknown at the time of this report.; Sender's Comments: Very limited information regarding this events has been provided at this time.Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Anosmia, Chills, Dizziness, Fatigue, Influenza like illness
Clinical narrative: flu like symptoms; extremally dizzy; shaky; chills; body ache; nausea; fatigue; diminished smell; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills) and PAIN (body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills), PAIN (body ache), NAUSEA (nausea), FATIGUE (fatigue) and ANOSMIA (diminished smell). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills), PAIN (body ache), NAUSEA (nausea), FATIGUE (fatigue) and ANOSMIA (diminished smell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  Treatment details included Advil and Tylenol..   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness, Pain
Clinical narrative: flu like symptoms; extremally dizzy; shaky; chills; body ache; nausea; fatigue; diminished smell; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills) and PAIN (body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills), PAIN (body ache), NAUSEA (nausea), FATIGUE (fatigue) and ANOSMIA (diminished smell). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), DIZZINESS (extremally dizzy), NERVOUSNESS (shaky), CHILLS (chills), PAIN (body ache), NAUSEA (nausea), FATIGUE (fatigue) and ANOSMIA (diminished smell) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  Treatment details included Advil and Tylenol..   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia
Clinical narrative: moderate chills; body pain; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of CHILLS (moderate chills) and MYALGIA (body pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced CHILLS (moderate chills) and MYALGIA (body pain). At the time of the report, CHILLS (moderate chills) and MYALGIA (body pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No relevant concomitant medications were reported.  No treatment was reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Heart rate increased, Limb discomfort, Miliaria
Clinical narrative: cold sensation on my legs; shivers, feeling cold; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee; fast heart beat 1st hour after vaccine; headache; This spontaneous case was reported by a consumer and describes the occurrence of MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs) and CHILLS (shivers, feeling cold) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEART RATE INCREASED (fast heart beat 1st hour after vaccine) and HEADACHE (headache). On 05-Feb-2021, the patient experienced MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), CHILLS (shivers, feeling cold) and RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee). On an unknown date, the patient experienced LIMB DISCOMFORT (cold sensation on my legs). At the time of the report, MILIARIA (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), RASH MACULAR (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee), HEART RATE INCREASED (fast heart beat 1st hour after vaccine), LIMB DISCOMFORT (cold sensation on my legs), CHILLS (shivers, feeling cold), RASH (rash inside my legs, not itchy more like hives or prickly heat, tiny little red dots extended at the top of my knee) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication were not provided No treatment medications were not provided   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Followup received on 07-MAY-2021 and contains e-mail details.